comparemela.com
Home
Live Updates
Moderna, Inc.: Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates : comparemela.com
Moderna, Inc.: Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29Moderna
Related Keywords
Puerto Rico
,
Norway
,
Malaysia
,
Australia
,
Taiwan
,
Japan
,
United States
,
Hong Kong
,
United Kingdom
,
Madrid
,
Spain
,
Canada
,
Bancel
,
Rhôalpes
,
France
,
Germany
,
Bangladesh
,
India
,
Netherlands
,
Denmark
,
Kuwait
,
Singapore
,
Belgium
,
Italy
,
Sweden
,
Cambridge
,
Cambridgeshire
,
South Korea
,
Poland
,
Switzerland
,
American
,
Lavina Talukdar
,
Intratumoral Immuno
,
Juan Andres
,
Asia Pacific
,
Colleen Hussey
,
Noubar Afeyan
,
Us Department Of Defense
,
Research Development
,
Nasdaq
,
Development Expenses
,
Astrazeneca
,
Moderna Inc
,
Vertex Pharmaceuticals
,
Company Recognition
,
Summary Of Program
,
Institute For Life Changing Medicines
,
National Institutes Of Health
,
World Health Organization
,
Artificial Intelligence Ai Academy
,
Drug Administration
,
Exchange Commission
,
Vaccine Development
,
Share Repurchase Program
,
American Heart Association Scientific Sessions
,
Melinda Gates Foundation
,
Ai Academy
,
Thermo Fisher
,
National Academy Of Engineering
,
European Union
,
Vaccine Research Center
,
Carnegie Mellon University
,
Moderna Charitable Foundation
,
Vaccine Initiative
,
Corporate Communications
,
European Medicines Agency
,
Health Canada
,
Therapeutic Goods Administration
,
Chief Executive Officer
,
Goods Administration
,
Biologics License Application
,
Propionic Acidemia
,
Methylmalonic Acidemia
,
Program Highlights
,
Receptor Binding Domain
,
N Terminal Domain
,
Fast Track
,
National Institutes
,
Research Center
,
Cell Surface Therapeutics
,
Regenerative Therapeutics
,
Astrazeneca Led Phase
,
American Heart Association
,
Scientific Sessions
,
Intracellular Therapeutics
,
Drug Designation
,
Najjar Syndrome Type
,
Crigler Najjar Syndrome Type
,
Rare Pediatric Disease
,
Life Changing Medicines
,
Full Year
,
Administrative Expenses
,
Income Taxes
,
Per Share
,
Cash Provided
,
Operating Activities
,
Purchase Agreements
,
Effective Tax Rate
,
Repurchase Program
,
Charitable Foundation
,
Manufacturing Partnerships
,
Artificial Intelligence
,
Science Careers
,
Andres Elected
,
National Academy
,
Chief Technical Operations
,
Quality Officer
,
Moderna Annual Meeting
,
Analyst Event
,
Private Securities Litigation Reform Act
,
Annual Report
,
Vice President
,
Infect Dis Now
,
Moderna
,
Reports
,
Fourth
,
Quarter
,
Iscal
,
Ear
,
021
,
Financial
,
Results
,
Rovides
,
Business
,
Updates
,
comparemela.com © 2020. All Rights Reserved.